fetal cardiology


Quantitative Assessment of Fetal Ventricular Function

Quantitative Assessment of Fetal Ventricular Function:
Establishing Normal Values of the Myocardial Performance Index in the Fetus
Benjamin W. Eidem, M.D., Jeanette M. Edwards, M.D., and Frank Cetta, M.D.
Department of Pediatrics, Section of Pediatric Cardiology, Loyola University Medical Center,
Maywood, Illinois


Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Digilio MC,1 Marino B,2 Capolino R,1 Dallapiccola B.3 Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr Cardiol 2005;23:23-34
1 Medical Genetics, Bambino Gesù Hospital, Rome, Italy
2 Pediatric Cardiology, Institute of Pediatrics, University “La Sapienza”, Rome, Italy
3 Experimental Medicine and Pathology, University “La Sapienza”, and CSS-Mendel Institute, Rome, Italy

Abstract

Deletion 22q11.2 syndrome (Del22) (DiGeorge/Velo-Cardio-Facial syndrome) is characterized by congenital heart defect (CHD), palatal anomalies, facial dysmorphisms, neonatal hypocalcemia, immune deficit, speech and learning disabilities. CHD is present in 75% of patients with Del22.


Ultrasonic Biophysical Measurements in the Normal Human Fetus for Optimal Design of the Monolithic Fetal Pacemaker

Ultrasonic Biophysical Measurements in the Normal Human Fetus for Optimal Design of the Monolithic
Fetal Pacemaker
Evgueni Fayn, MD, Howard A. Chou, PhD, DaeGyun Park, MD, PhD, Daniel H. Zavitz, MSc, Bettina F. Cuneo, MD, Vicki L. Mahan, MD, Mehmet Guleçyuz, MD, Letitia Curran, RDMS, David Lipson, PhD,
Edmond W. Quillen, Jr., PhD, Boris M. Petrikovsky, MD, PhD, and Marc Ovadia, MD

The failures of current medical therapeutics for the management of fetal complete atrioventricular
block with hydrops fetalis, as well as the increasing number of fetuses at risk for acute bradycardia during interventional procedures and fetal surgeries, have inspired the author of this article to develop a monolithic pacemaker designed for closed-thorax, closed-uterus, closed–maternal abdomen over-the-wire deployment under ultrasound guidance.


Fetal supraventricular tachycardia

Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: a case report
Romeo E, D’Alto M, Russo MG, Sarubbi B, Cardaropoli D, Paladini D, Pacileo G, Annunziata A, Calabrò R
Chair of Cardiology, Second University of Naples, Naples, Italy

Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction.


Atrial septal aneurysm in high risk fetuses

Prevalence and prognosis of atrial septal aneurysm in high risk fetuses without structural heart defects
Papa M, Fragasso G, Camesasca C, Di Turi RP, Spagnolo D, Valsecchi L, Calori G, Margonato A
Division of Cardiology, Scientific Institute/University San Raffaele, Milan, Italy

BACKGROUND.
The aim of this study was to evaluate the prevalence and prognostic implications of the association between atrial septal aneurysm (ASA) and fetal arrhythmias in a population of high risk fetuses.<


Right Ventricular Pre-ejection Myocardial Velocity and Myocardial Acceleration in Normal Fetuses Assessed by Doppler Tissue Imaging

Right Ventricular Pre-ejection Myocardial Velocity and Myocardial Acceleration in Normal Fetuses Assessed by Doppler Tissue Imaging

Kenji Harada, MD, Masaki Ogawa, MD, and Toshinobu Tanaka, MD, Akita, Japan

Myocardial acceleration during isovolumic contraction obtained from Doppler tissue imaging has been introduced as an index of right ventricular contractile function that is unaffected by the shape of the ventricle and loading conditions, but normal value of myocardial acceleration during isovolumic contraction and the effect of aging on the index are not known in normal fetuses.


Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies

Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies

Marie-Josée Raboisson, MD a 1 – Jean-Claude Fouron, MD a – Sven-Erik Sonesson, MD b –
Margareta Nyman, MD c – Francine Proulx, RT a – Sylvie Gamache, RT a

Abstract

Background Complete fetal heart block (HB) and endocardial fibroelastosis (EFE) are known to be associated with maternal anti-Ro and anti-La antibodies. Complete fetal HB is irreversible.


[Echogenic intracardiac structures (golf ball phenomenon)

Ultraschall Med. 1999 Feb;20(1):19-21. (German)

[Echogenic intracardiac structures (golf ball phenomenon) as predictors of chromosome anomalies]

Bettelheim D, Ulm MR, Deutinger J, Bernaschek G.

Universitatsklinik fur Frauenheilkunde, Abteilung fur Pranatale Diagnostik und Therapie, Wien.